These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26582474)

  • 1. The cytoplasmic domain is essential for transport function of the integral membrane transport protein SLC4A11.
    Loganathan SK; Lukowski CM; Casey JR
    Am J Physiol Cell Physiol; 2016 Jan; 310(2):C161-74. PubMed ID: 26582474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biochemical framework for SLC4A11, the plasma membrane protein defective in corneal dystrophies.
    Vilas GL; Morgan PE; Loganathan SK; Quon A; Casey JR
    Biochemistry; 2011 Mar; 50(12):2157-69. PubMed ID: 21288032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC4A11 Three-Dimensional Homology Model Rationalizes Corneal Dystrophy-Causing Mutations.
    Badior KE; Alka K; Casey JR
    Hum Mutat; 2017 Mar; 38(3):279-288. PubMed ID: 27925686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional assessment of SLC4A11, an integral membrane protein mutated in corneal dystrophies.
    Loganathan SK; Schneider HP; Morgan PE; Deitmer JW; Casey JR
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C735-C748. PubMed ID: 27558157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Throughput Assay Identifies Glafenine as a Corrector for the Folding Defect in Corneal Dystrophy-Causing Mutants of SLC4A11.
    Chiu AM; Mandziuk JJ; Loganathan SK; Alka K; Casey JR
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7739-53. PubMed ID: 26641551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmic Nonsteroidal Anti-Inflammatory Drugs as a Therapy for Corneal Dystrophies Caused by SLC4A11 Mutation.
    Alka K; Casey JR
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4258-4267. PubMed ID: 30140924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective cell adhesion function of solute transporter, SLC4A11, in endothelial corneal dystrophies.
    Malhotra D; Jung M; Fecher-Trost C; Lovatt M; Peh GSL; Noskov S; Mehta JS; Zimmermann R; Casey JR
    Hum Mol Genet; 2020 Jan; 29(1):97-116. PubMed ID: 31691803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular phenotype of SLC4A11 missense mutants: Setting the stage for personalized medicine in corneal dystrophies.
    Alka K; Casey JR
    Hum Mutat; 2018 May; 39(5):676-690. PubMed ID: 29327391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomerization of SLC4A11 protein and the severity of FECD and CHED2 corneal dystrophies caused by SLC4A11 mutations.
    Vilas GL; Loganathan SK; Quon A; Sundaresan P; Vithana EN; Casey J
    Hum Mutat; 2012 Feb; 33(2):419-28. PubMed ID: 22072594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeostasis of SLC4A11 protein is mediated by endoplasmic reticulum-associated degradation.
    Hara S; Tsujikawa M; Kawasaki S; Nishida K
    Exp Eye Res; 2019 Nov; 188():107782. PubMed ID: 31491427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human SLC4A11 Is a Novel NH3/H+ Co-transporter.
    Zhang W; Ogando DG; Bonanno JA; Obukhov AG
    J Biol Chem; 2015 Jul; 290(27):16894-905. PubMed ID: 26018076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC4A11 and the Pathophysiology of Congenital Hereditary Endothelial Dystrophy.
    Patel SP; Parker MD
    Biomed Res Int; 2015; 2015():475392. PubMed ID: 26451371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional ion transport properties of human SLC4A11: comparison of the SLC4A11-B and SLC4A11-C variants.
    Kao L; Azimov R; Shao XM; Frausto RF; Abuladze N; Newman D; Aldave AJ; Kurtz I
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C820-C830. PubMed ID: 27581649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse Slc4a11 expressed in Xenopus oocytes is an ideally selective H+/OH- conductance pathway that is stimulated by rises in intracellular and extracellular pH.
    Myers EJ; Marshall A; Jennings ML; Parker MD
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C945-C959. PubMed ID: 27681179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missense mutations in the sodium borate cotransporter SLC4A11 cause late-onset Fuchs corneal dystrophy.
    Riazuddin SA; Vithana EN; Seet LF; Liu Y; Al-Saif A; Koh LW; Heng YM; Aung T; Meadows DN; Eghrari AO; Gottsch JD; Katsanis N
    Hum Mutat; 2010 Nov; 31(11):1261-8. PubMed ID: 20848555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R125H, W240S, C386R, and V507I SLC4A11 mutations associated with corneal endothelial dystrophy affect the transporter function but not trafficking in PS120 cells.
    Li S; Hundal KS; Chen X; Choi M; Ogando DG; Obukhov AG; Bonanno JA
    Exp Eye Res; 2019 Mar; 180():86-91. PubMed ID: 30557570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC4A11 depletion impairs NRF2 mediated antioxidant signaling and increases reactive oxygen species in human corneal endothelial cells during oxidative stress.
    Guha S; Chaurasia S; Ramachandran C; Roy S
    Sci Rep; 2017 Jun; 7(1):4074. PubMed ID: 28642546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular physiology of SLC4 anion exchangers.
    Alper SL
    Exp Physiol; 2006 Jan; 91(1):153-61. PubMed ID: 16239253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal dystrophy-causing SLC4A11 mutants: suitability for folding-correction therapy.
    Loganathan SK; Casey JR
    Hum Mutat; 2014 Sep; 35(9):1082-91. PubMed ID: 24916015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ion transport function of SLC4A11 in corneal endothelium.
    Jalimarada SS; Ogando DG; Vithana EN; Bonanno JA
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4330-40. PubMed ID: 23745003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.